Novavax (NVAX) Files For UK Authorization of its COVID-19 Vaccine
Go back to Novavax (NVAX) Files For UK Authorization of its COVID-19 Vaccine| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 9.09 +0.06 (0.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.03 | 52 Week High | $9.23 | |||
| Open | $9.14 | 52 Week Low | $1.16 | |||
| Day High | $9.30 | P/E | N/A | |||
| Day Low | $9.05 | EPS | $-0.30 | |||
| Volume | 252,862 | |||||

